Literature DB >> 22531555

An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analyses.

D L McClure1, S Xu, E Weintraub, J M Glanz.   

Abstract

In the US, the Vaccine Safety Datalink (VSD) project, sponsored by the Centers for Disease Control and Prevention, conducts near-real-time, population-based, active surveillance for vaccine safety. One of the steps in analyzing signals, if there are enough cases, is to apply temporal scan statistics. The purpose is to determine if the cases clustered in time within an overall a priori defined post-vaccination observation interval. We presented a relatively efficient and accurate algorithm for the purely temporal scan statistic as applied to vaccine safety investigations. It only needs SAS/BASE(®) software, and the algorithm is simple enough to be programmed in another software languages. Our present work is focused on incorporating the temporal scan statistic algorithm within our previous approach for finding an optimal risk window for studies of vaccine safety.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531555     DOI: 10.1016/j.vaccine.2012.04.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine.

Authors:  James G Donahue; Burney A Kieke; Edwin M Lewis; Eric S Weintraub; Kayla E Hanson; David L McClure; Elizabeth R Vickers; Julianne Gee; Matthew F Daley; Frank DeStefano; Rulin C Hechter; Lisa A Jackson; Nicola P Klein; Allison L Naleway; Jennifer C Nelson; Edward A Belongia
Journal:  Pediatrics       Date:  2019-11-18       Impact factor: 7.124

2.  Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.

Authors:  Elizabeth R Vickers; David L McClure; Allison L Naleway; Steven J Jacobsen; Nicola P Klein; Jason M Glanz; Eric S Weintraub; Edward A Belongia
Journal:  Vaccine       Date:  2017-09-06       Impact factor: 3.641

Review 3.  Enhancing vaccine safety capacity globally: A lifecycle perspective.

Authors:  Robert T Chen; Tom T Shimabukuro; David B Martin; Patrick L F Zuber; Daniel M Weibel; Miriam Sturkenboom
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

4.  Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia.

Authors:  Hazel J Clothier; Jock Lawrie; Melissa A Russell; Heath Kelly; Jim P Buttery
Journal:  PLoS One       Date:  2019-11-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.